Effect of a mind-body intervention Liuzijue for patients with chronic heart failure: a randomized controlled trial.

Phase 1

• Conditions: Chronic heart failure

• Registration Number: ITMCTR1900002431
• Lead Sponsor: Dongguan Donghua Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Those who meet the diagnostic criteria for heart failure; (2) aged 50 to 75 years; (3) NYHA grade I-III; (4) the symptoms and signs of chronic heart failure are stable for more than 1 month; (5) consciousness, no obvious obstacles in hearing and intelligence, can cooperate with rehabilitation training; (6) sign the informed consent form.

Exclusion Criteria

(1) Patients with severe renal or hepatic insufficiency, chronic obstructive pulmonary disease or pulmonary heart disease; (2) severe primary diseases such as severe hematopoietic system and tumor; (3) heart valve disease, cardiomyopathy or congenital heart disease; (4) poor control of hypertension (at rest, systolic blood pressure > 200mmHg or diastolic blood pressure > 110mmHg); (5) other metabolic problems, such as hyperkalemia, hypokalemia, acute thyroiditis, etc.; (6) Patients who have practiced the practice method in the past 3 months (including Liu Zi, Ba Duan Jin, Tai Chi, etc.).

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Peak oxygen consumption;